Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.030
-0.040 (-1.93%)
At close: Dec 5, 2025, 4:00 PM EST
2.000
-0.030 (-1.48%)
After-hours: Dec 5, 2025, 5:49 PM EST
Nautilus Biotechnology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 256 | 211 | 374 | 225 | 643 | - | |
| Market Cap Growth | -8.84% | -43.55% | 66.44% | -65.09% | - | - | |
| Enterprise Value | 152 | 102 | 226 | -4 | 299 | - | |
| Last Close Price | 2.03 | 1.68 | 2.99 | 1.80 | 5.18 | 10.85 | |
| PB Ratio | 1.52 | 1.01 | 1.41 | 0.71 | 1.77 | - | |
| P/TBV Ratio | 1.52 | 1.01 | 1.41 | 0.71 | 1.77 | - | |
| Debt / Equity Ratio | 0.16 | 0.15 | 0.13 | 0.10 | 0.08 | 0.06 | |
| Quick Ratio | 14.63 | 17.02 | 19.01 | 27.16 | 59.49 | 25.43 | |
| Current Ratio | 14.96 | 17.40 | 19.39 | 27.57 | 60.09 | 25.73 | |
| Return on Equity (ROE) | -32.00% | -29.86% | -21.95% | -17.07% | -22.75% | -32.29% | |
| Return on Assets (ROA) | -19.37% | -18.57% | -14.52% | -10.62% | -13.06% | -19.00% | |
| Return on Capital (ROIC) | -19.78% | -18.89% | -14.75% | -10.76% | -13.23% | -19.38% | |
| Return on Capital Employed (ROCE) | -37.20% | -34.70% | -25.70% | -18.50% | -12.90% | -19.20% | |
| Earnings Yield | -24.50% | -33.55% | -17.04% | -25.80% | -7.82% | - | |
| FCF Yield | -21.32% | -29.40% | -14.49% | -21.44% | -6.45% | - | |
| Buyback Yield / Dilution | -0.71% | -0.41% | -0.27% | -47.51% | -190.36% | -379.48% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.